Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Promethera Biosciences SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10881
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among others. Promethera provides hepastem which is a therapeutic product, designed to treat liver diseases by allogeneic liver injection of HHALPC. The company also undertakes clinical studies. It develops liver cell-based technologies to bringing therapeutic solutions for patients with acute and chronic liver diseases. The company collaborates with research institutes and pharmaceutical companies for its research activities. Promethera is headquartered in Nivelles, Belgium.

Promethera Biosciences SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Promethera Biosciences SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Promethera Biosciences Acquires Assets of Cytonet 11
Venture Financing 12
Promethera Biosciences Raises USD11 Million in Extended Series C Financing 12
Promethera Biosciences Raises USD25 Million in Series C Venture Financing 14
PROMETHERA Biosciences Raises US$31.5 Million In Series B Financing 16
Partnerships 17
EMD Millipore Enters Into Co-Development Agreement With Promethera Biosciences 17
Licensing Agreements 18
Lifeliver Enters into Licensing Agreement with Promethera Biosciences 18
Baliopharm Enters Into Licensing Agreement With ApoGbR For Novotarg 19
Debt Offering 20
Promethera Biosciences Raises USD11.4 Million in Private Placement of Bonds 20
Acquisition 21
Promethera Biosciences Acquires Baliopharm 21
Promethera Biosciences SA – Key Competitors 22
Promethera Biosciences SA – Key Employees 23
Promethera Biosciences SA – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Oct 05, 2018: Promethera Biosciences names Mutsuki Takano to Group Chief Financial Officer 25
Apr 06, 2018: Promethera Biosciences Announces Updates to its Board of Directors Charles L. Dimmler, III elected as new Chairman of the Board 26
Nov 21, 2017: Promethera Biosciences Provides Update on Executive Management Team 27
Feb 09, 2017: Promethera Biosciences Announces Key Additions to its Executive Management Team 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Key Facts 2
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Promethera Biosciences SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Promethera Biosciences SA, Deals By Therapy Area, 2012 to YTD 2018 8
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Promethera Biosciences Acquires Assets of Cytonet 11
Promethera Biosciences Raises USD11 Million in Extended Series C Financing 12
Promethera Biosciences Raises USD25 Million in Series C Venture Financing 14
PROMETHERA Biosciences Raises US$31.5 Million In Series B Financing 16
EMD Millipore Enters Into Co-Development Agreement With Promethera Biosciences 17
Lifeliver Enters into Licensing Agreement with Promethera Biosciences 18
Baliopharm Enters Into Licensing Agreement With ApoGbR For Novotarg 19
Promethera Biosciences Raises USD11.4 Million in Private Placement of Bonds 20
Promethera Biosciences Acquires Baliopharm 21
Promethera Biosciences SA, Key Competitors 22
Promethera Biosciences SA, Key Employees 23
Promethera Biosciences SA, Other Locations 24
Promethera Biosciences SA, Subsidiaries 24

List of Figures
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Promethera Biosciences SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Pinnacle Investment Management Group Limited (PNI):企業の財務・戦略的SWOT分析
    Pinnacle Investment Management Group Limited (PNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Kawasaki Kisen Kaisha Ltd (9107):石油・ガス:M&Aディール及び事業提携情報
    Summary Kawasaki Kisen Kaisha Ltd (K Line) is a global logistics company. It provides land transportation, air transportation, marine transportation, and harbor transportation. It owns and operates dry bulk carriers, LNG carriers, tankers, car carriers and containerships. The company also provides s …
  • Sareum Holdings Plc (SAR)-製薬・医療分野:企業M&A・提携分析
    Summary Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, SKIL (Sareum Kinase Inhib …
  • Husqvarna AB (HUSQ B):企業の財務・戦略的SWOT分析
    Summary Husqvarna AB (Husqvarna) is an industrial equipment company. The company produces outdoor power products for forestry, gardening and construction. It offers wheeled products, electric products. Husqvarna also provides handheld products, watering and hand tools, accessories, and construction …
  • CommInsure:企業の戦略・SWOT・財務情報
    CommInsure - Strategy, SWOT and Corporate Finance Report Summary CommInsure - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Air China Limited:戦略・SWOT・企業財務分析
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Consolidated Edison Inc (ED):電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Boston Children’s Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Gujarat State Petroleum Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Petroleum Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Companhia Riograndense de Mineracao:企業の戦略・SWOT・財務分析
    Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report Summary Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Vattenfall AB.:企業の戦略・SWOT・財務分析
    Vattenfall AB. - Strategy, SWOT and Corporate Finance Report Summary Vattenfall AB. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Generex Biotechnology Corp (GNBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulatio …
  • Taiwan Shin Kong Commercial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Shin Kong Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Shin Kong Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • BARMER GEK:企業の戦略的SWOT分析
    BARMER GEK - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Clydesdale Bank PLC:企業の戦略的SWOT分析
    Clydesdale Bank PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bristol-Myers Squibb Company:企業のM&A・事業提携・投資動向
    Bristol-Myers Squibb Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bristol-Myers Squibb Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Logicalis Group Ltd:企業の戦略的SWOT分析
    Logicalis Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Covalon Technologies Ltd (COV):医療機器:M&Aディール及び事業提携情報
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆